TY - JOUR
T1 - The t(14;18) in diffuse large B-cell lymphoma
T2 - Correlation with germinal center-associated markers and clinical features
AU - Xu, Yin
AU - McKenna, Robert W.
AU - Doolittle, Jeffrey E.
AU - Hladik, Christa L.
AU - Kroft, Steven H.
PY - 2005/6
Y1 - 2005/6
N2 - The clinical and biologic relevance of the t(14;18) and features of germinal center (GC) differentiation in diffuse large B-cell lymphoma (DLBCL) remain controversial. The authors examined the association of t(14;18) with GC-associated markers and clinical features in 44 de novo DLBCLs (22 nodal and 22 primary extranodal). CD10, bcl-2, and bcl-6 were expressed in 50%, 62%, and 54% of cases respectively. There were no significant differences in expression of these markers between nodal and extranodal cases. Coexpression of CD10 and bcl-6 was seen in 12 of 41 cases, and was more frequent in nodal than extranodal DLBCL (9 of 21 vs. 3 of 20; P = 0.05). A CD10(+)/bcl-6(+) phenotype was not significantly associated with bcl-2 expression, stage, complete remission rate, or survival. The t(14;18) was found in 7 of 44 (16%) cases (6 nodal, 1 extranodal; P = 0.09). It was associated with a CD10(+)/bcl-6(+) phenotype (5 of 7 vs. 7 of 27; P = 0.015) and a trend toward more frequent bcl-6 expression (6 of 7 vs. 15 of 34; P = 0.09), but no association with bcl-2 expression, CD10, clinical stage, complete remission, or survival. Among nodal or high-stage (III-IV) DLBCL, cases with the t(14;18) showed a trend toward decreased survival (P = 0.12).
AB - The clinical and biologic relevance of the t(14;18) and features of germinal center (GC) differentiation in diffuse large B-cell lymphoma (DLBCL) remain controversial. The authors examined the association of t(14;18) with GC-associated markers and clinical features in 44 de novo DLBCLs (22 nodal and 22 primary extranodal). CD10, bcl-2, and bcl-6 were expressed in 50%, 62%, and 54% of cases respectively. There were no significant differences in expression of these markers between nodal and extranodal cases. Coexpression of CD10 and bcl-6 was seen in 12 of 41 cases, and was more frequent in nodal than extranodal DLBCL (9 of 21 vs. 3 of 20; P = 0.05). A CD10(+)/bcl-6(+) phenotype was not significantly associated with bcl-2 expression, stage, complete remission rate, or survival. The t(14;18) was found in 7 of 44 (16%) cases (6 nodal, 1 extranodal; P = 0.09). It was associated with a CD10(+)/bcl-6(+) phenotype (5 of 7 vs. 7 of 27; P = 0.015) and a trend toward more frequent bcl-6 expression (6 of 7 vs. 15 of 34; P = 0.09), but no association with bcl-2 expression, CD10, clinical stage, complete remission, or survival. Among nodal or high-stage (III-IV) DLBCL, cases with the t(14;18) showed a trend toward decreased survival (P = 0.12).
KW - CD10
KW - Diffuse large B-cell lymphoma
KW - bcl-2
KW - bcl-2 translocation
KW - bcl-6
UR - http://www.scopus.com/inward/record.url?scp=19444367343&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=19444367343&partnerID=8YFLogxK
U2 - 10.1097/01.pai.0000129055.93199.2b
DO - 10.1097/01.pai.0000129055.93199.2b
M3 - Article
C2 - 15894922
AN - SCOPUS:19444367343
SN - 1541-2016
VL - 13
SP - 116
EP - 123
JO - Applied Immunohistochemistry and Molecular Morphology
JF - Applied Immunohistochemistry and Molecular Morphology
IS - 2
ER -